This results in a more consistent, non-jittery improvement in metabolic efficiency
This helps with both normal mitochondria degradation as well as mitochondrial dysfunction-related conditions such as heart failure, ischemia-reperfusion injury, neurodegenerative diseases, and metabolic disorders
Its a great pick-me-up for anyone needing a boost without caffeine crashes
A separate product, semaglutide subcutaneous injection (Wegovy), is indicated as an adjunct to lifestyle modifications for weight loss and chronic weight management in obese (BMI 30 kg/m2 or greater) or overweight adults (BMI 27 kg/m2 or greater) with at least 1 weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
Note: Any adverse reactions should be reported via the Yellow Card scheme